Tyra Biosciences Inc (TYRA, Financial), a company focused on developing precision medicine for patients with cancer, has reported an insider sell according to a recent SEC filing. Daniel Bensen, the Chief Operating Officer of Tyra Biosciences Inc, sold 9,152 shares of the company on March 5, 2024. The transaction was disclosed in an SEC Filing.
Over the past year, the insider, Daniel Bensen, has sold a total of 274,297 shares and has not made any purchases of the company's stock. The recent sell by the insider is part of a trend observed over the past year, where there have been no insider buys and 22 insider sells for Tyra Biosciences Inc.
On the day of the insider's recent sell, shares of Tyra Biosciences Inc were trading at $20.06. The company currently holds a market cap of $1.016 billion.
For more information on insider trades and the financial performance of Tyra Biosciences Inc (TYRA), investors and shareholders are encouraged to review the full details of the SEC filing and follow the company's updates.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
